Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glycopyrrolate Inhalation Solution (GIS) in COPD
NCT02951312Phase 2Completed
- Sponsor
- Sunovion
- Start
- May 2009
- Primary completion
- Jul 2009
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of glycopyrrolate metered dose inhaler in chronic obstructive pulmonary disease (COPD) (7 arms), sponsored by Sunovion. Primary endpoints: Number of Subjects Who Died, Number of Subjects With Treatment Emergent SAEs and 4 more. Started May 2009; status: completed.
02
Drugs
glycopyrrolate metered dose inhaler
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02951312.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02951312.